Adverse events following introduction of the ChAdOx1 nCoV-19 vaccine in Somalia in 2021: findings from a fragile setting and implications for the future

BACKGROUND: Vaccination against coronavirus disease 2019 (COVID-19) began in Somalia on 16 March 2021 with the Covishield (ChAdOx1 nCoV-19) vaccine. However, by the end of 2021, only a small percentage of the population had been fully vaccinated. As side effects play an important role in determining...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamayoun, Mohammad, Abdulrazak, Ibrahim, Farid, Muhammad, Malik, Mamunur Rahman, Mohamud, Mohammed Farah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Coronavirus (COVID-19) Collection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169432/
https://www.ncbi.nlm.nih.gov/pubmed/35720961
http://dx.doi.org/10.1016/j.ijregi.2022.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169432/
https://www.ncbi.nlm.nih.gov/pubmed/35720961
http://dx.doi.org/10.1016/j.ijregi.2022.06.001

Ejemplares similares